Advertisement
Rapid CommunicationShort Communication

Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats

Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Rapid CommunicationShort Communication

Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats

Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
Drug Metabolism and Disposition May 1, 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement